SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Tempest Therapeutics Faces Nasdaq Delisting Over Equity Shortfall

Tempest Therapeutics faces Nasdaq delisting over a stockholders’ equity shortfall.

TPST

Related stories